CapForce IBD Breakout Opportunities ETF
BOUT
12 hedge funds and large institutions have $1.97M invested in CapForce IBD Breakout Opportunities ETF in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
9% more funds holding
Funds holding: 11 → 12 (+1)
4.6% less ownership
Funds ownership: 15.05% → 10.44% (-4.6%)
29% less capital invested
Capital invested by funds: $2.75M → $1.97M (-$786K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$386K |
| 2 |
CFA
Cahill Financial Advisors
Edina,
Minnesota
|
+$39.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$27.8K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$11.6K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$8.64K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
-$707K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$522K |
| 3 |
APA
American Portfolios Advisors
Holbrook,
New York
|
-$93.3K |
| 4 |
SWM
Selective Wealth Management
Forest,
Virginia
|
-$3.46K |
BOUT Hedge Fund Activity: Q3 2021 in Review
12 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD Breakout Opportunities ETF (BOUT) for Q3 2021, worth a combined $1.97M — down 29% from $2.75M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BOUT positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $386K. The largest seller was Flow Traders U.S., exiting entirely with an estimated $707K sold.
- 12 institutional investors held CapForce IBD Breakout Opportunities ETF (BOUT) as of Q3 2021, up from 11 in Q2 2021.
- Funds reported $1.97M of CapForce IBD Breakout Opportunities ETF stock for Q3 2021, down 29% quarter-over-quarter.
- 2 funds opened new CapForce IBD Breakout Opportunities ETF positions in Q3 2021 and 1 closed out, a net change of +1 holder.
- The largest CapForce IBD Breakout Opportunities ETF buyer in Q3 2021 was Citadel Advisors, an estimated $386K added.
- The largest CapForce IBD Breakout Opportunities ETF seller in Q3 2021 was Flow Traders U.S., an estimated $707K sold.
Based on aggregated 13F filings for Q3 2021.